Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients

PURPOSE: Only a few studies are available on dose-related effects of sacubitril/valsartan (angiotensin receptor neprilysin inhibition (ARNI)) in real-life patients with heart failure and reduced ejection fraction (HFrEF). We sought to investigate clinical and functional effects in real-life HFrEF pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrado, Egle, Dattilo, Giuseppe, Coppola, Giuseppe, Morabito, Claudia, Bonni, Enrico, Zappia, Luca, Novo, Giuseppina, de Gregorio, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458558/
https://www.ncbi.nlm.nih.gov/pubmed/34554274
http://dx.doi.org/10.1007/s00228-021-03210-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458558/
https://www.ncbi.nlm.nih.gov/pubmed/34554274
http://dx.doi.org/10.1007/s00228-021-03210-0

Ejemplares similares